PFE Stock Recent News
PFE LATEST HEADLINES
In the latest trading session, Pfizer (PFE) closed at $26.58, marking a -0.3% move from the previous day.
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pfizer has had plenty of bad news, with more on the way. New products and acquisitions should help the drugmaker return to growth.
The Investment Committee gives you their top stocks to watch for the second half.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
The first quarter of the year was a success for investors. The overall market NYSE: SPY surged nearly 10%, fueled by robust economic indicators, optimism, and hype surrounding AI.
Viking Therapeutics may be on the verge of a breakthrough obesity care treatment. Right now, obesity care and diabetes are dominated by Novo Nordisk and Eli Lilly.
Check out the guide to the best dividend stocks that can help you achieve financial freedom. The first star in this investing galaxy, with a 5% dividend yield, is glowing brightly.
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Where to invest today according to our three experts